Metabiomed Amends Interim Dividend Disclosure, Slight Change in Total Dividend Due to Additional Treasury Share Acquisition

Metabiomed revised its interim dividend disclosure dated June 25, 2026, adjusting the total dividend payout from KRW 1,458,129,475 to KRW 1,454,279,475.
The amendment reflects an increase in treasury shares from 660,000 to 730,000 as of the record date, while the per-share dividend of KRW 55 and dividend yield of 1.5% remain unchanged.
The dividend is funded from capital reserves converted to retained earnings, making it tax-free for shareholders.
The company continues its share buyback program alongside the dividend to enhance shareholder value.
[AI Summary]This correction is a minor adjustment in total payout due to additional treasury stock acquisition, with negligible financial impact. The unchanged dividend per share and ongoing buyback policy support shareholder returns, while the tax-free structure remains a positive feature.